Nanomedicine strategies for overcoming cellular and microenvironmental barriers to cuproptosis-based cancer therapy.
Cuproptosis, a copper-dependent form of regulated cell death driven by mitochondrial proteotoxic stress, has emerged as a promising vulnerability for cancer therapy. However, its therapeutic translation is limited by cellular and microenvironmental barriers that restrict effective copper delivery, intracellular copper...